Company / Current Liabilities per Share
Sonoma Pharmaceuticals, Inc. Current Liabilities per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$5.25
FY2025
5-year range
$0.75 / $5.25
FY2021-FY2025
Trend
+596.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share changed +596% YoY in FY2025, a notable deviation from the 8-year average annual change of +130%.
Based on SEC 10-K filings.
5.25 in FY2025 with a 5-year CAGR of +7.3%.
Increased from $1.20 to $5.25 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +23.6%
- 5-Year CAGR
- +7.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share increased 596.3% year-over-year.
- Lowest current liabilities per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | $5.25 | +596.3% |
| FY2024 | $0.75 | -37.1% |
| FY2023 | $1.20 | -56.9% |
| FY2022 | $2.78 | +21.2% |
| FY2021 | $2.29 | -37.9% |
| FY2020 | $3.70 | -29.4% |
| FY2019 | $5.24 | +588.8% |
| FY2018 | $0.76 | -3.0% |
| FY2017 | $0.78 | +231.9% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026